Valdar, W
The committee acknowledged the more recent indication that was approved for semaglutide (Wegovy) was to reduce the risk of non-fatal MI in adults with established CV disease and BMI equal to or greater than 27 kg/m 2 , but noted that the resubmission was submitted under the indication for weight management with a focus on patients with a history of CVD as per the sponsors decision
Common Contraindications and High-Risk Histories Based on FDA prescribing information for semaglutide products, clinicians commonly screen for: Personal or family history of medullary thyroid carcinoma , or related endocrine tumor syndromes Pregnancy or plans to become pregnant soon (timing and medical guidance matter) History of pancreatitis or severe unexplained abdominal pain episodes Gallbladder disease history, especially if symptoms recur Severe dehydration risk , especially if you already struggle with vomiting, diarrhea, or low fluid intake Situations That May Need Closer Monitoring Some people may still use semaglutide, but they may need extra follow-up
A Clear Conversion Guide If youve switched from a brand-name semaglutide pen to a compounded semaglutide vial, or if youre trying to make sense of your dosing instructions, youve probably run into this question: how many units is 1mg of semaglutide
Variations in product color may occur
